|
IMP: BOD resolution dated December 10, 2021 The Board resolution dated December 10, 2021, the BOD of Imexpharm Corporation approved the following contents:
1) Approving the record date to implement rights to collect shareholders’ opinions in writing:
- Record date: January 01, 2022
- Purpose: to collect shareholders’ opinions in writing.
- Content:
+Amendment, supplement of the company’s charter; Regulation on Corporate Internal Governance; Regulation on organizing online the General Meeting of Shareholders.
+Proposal on approving the maximum foreign ownership ratio at IMP to 75%
+Proposal on the public offer tender for the transfer of shares between SK Investment Vina III Pte. Ltd and its existing shareholders.
- Time of implementation: from January 12, 2022 to January 27, 2021.
2) Approving the documents to collect shareholders’ opinions in writing:
- Form to collect shareholders’ opinions in writing;
- Proposal on amendment, supplement of the company’s charter; Regulation on Corporate Internal Governance; Regulation on organizing online the General Meeting of Shareholders.
- Proposal on the maximum foreign ownership ratio at IMP to 75%.
- Proposal on the public offer tender for SK Investment Vina III Pte. Ltd.
- Draft of the Resolution of General Meeting of Shareholders. HOSE
|
